Merck & Co. reports $65.01 billion revenue for fiscal year ended December 31, 2025, up 1.3%
Merck & Co. reported revenue of $65.01 billion for the year ended December 31, 2025, an increase of 1.3% from the previous year ($64.17 billion).
For the same period it posted net income of $18.25 billion, up 6.6%, or $7.28 per diluted share (6.74 a year earlier).
That is a net margin of 28.1%.
On Sanad's AAOIFI Standard 21 screen, Merck & Co. is currently compliant: interest-bearing debt is 15.2% of market capitalisation (limit 30%), and impure income is 0.5% of revenue (limit 5%).
Is Merck & Co. halal?
See the full AAOIFI screening of Merck & Co.
See the full AAOIFI screening of Merck & Co.
Source: 10-K filed with the U.S. Securities and Exchange Commission on February 24, 2026. View the filing. Figures are as reported in the filing. This is information, not investment advice.